Table 4 Demographic details (propensity score matching; N = 102).
Total, N = 102 | Posterior spine stabilization with decompression (N = 51) | Posterior spine stabilization without decompression (N = 51) | P | |
|---|---|---|---|---|
Age | 66.7 (11.0) | 66.2 (10.9) | 67.4 (9.0) | 0.69 |
Male n (%) | 70 (68.6%) | 36 (70.6%) | 34 (66.7%) | 0.83 |
Breast Ca n (%) | 9 (8.8%) | 4 (7.8%) | 5 (9.8%) | 0.99 |
Lung Ca n (%) | 26 (25.5%) | 15 (29.4%) | 11 (21.6%) | 0.50 |
Prostate Ca n (%) | 9 (8.8%) | 6 (11.8%) | 3 (5.9%) | 0.49 |
Kidney Ca n (%) | 17 (16.7%) | 7 (13.7%) | 10 (19.6%) | 0.60 |
ESCC 0 n (%) | 4 (3.9%) | 2 (3.9%) | 2 (3.9%) | 0.86 |
ESCC 1a-c n (%) | 33 (32.4%) | 15 (29.4%) | 18 (35.3%) | |
ESCC2 n (%) | 47 (46.1%) | 26 (51.0%) | 21 (41.2%) | |
ESCC3 n (%) | 18 (17.7%) | 8 (15.7%) | 10 (19.6%) | |
Height (cm) | 161.4 (9.5) | 162.0 (8.8) | 161.6 (9.5) | 0.67 |
Weight (kg) | 57.7 (13.0) | 58.6 (14.3) | 57.5 (15.2) | 0.70 |
Frankel B n (%) | 3 (2.9%) | 1 (2.0%) | 2 (3.9%) | 0.54 |
Frankel C n (%) | 15 (14.7%) | 8 (15.7%) | 7 (13.7%) | |
Frankel D n (%) | 28 (27.5%) | 17 (33.3%) | 11 (21.6%) | |
Frankel E n (%) | 56 (54.9%) | 25 (49.0%) | 31 (60.8%) | |
PS 3,4 n (%) | 54 (53.0%) | 28 (54.9%) | 26 (51.0%) | 0.84 |
Pre chemotherapy n (%) | 41 (40.2%) | 19 (37.3%) | 22 (43.1%) | 0.69 |
Post chemotherapy n (%) | 58 (56.9%) | 33 (64.7%) | 25 (49.0%) | 0.16 |
Pre radiation n (%) | 29 (28.4%) | 12 (23.5%) | 17 (33.3%) | 0.38 |
Post radiation n (%) | 51 (50.0%) | 25 (49.0%) | 26 (51.0%) | 0.99 |
Pre Molecular Targeted Therapy n (%) | 26 (25.5%) | 17 (33.3%) | 9 (17.7%) | 0.11 |
Post Molecular Targeted Therapy n (%) | 37 (36.3%) | 19 (37.3%) | 18 (35.3%) | 0.99 |
Pre bone therapy n (%) | 31 (30.4%) | 14 (27.5%) | 17 (33.3%) | 0.66 |
Post bone therapy n (%) | 67 (65.7%) | 32 (62.8%) | 35 (68.6%) | 0.68 |
Pre opioid n (%) | 43 (42.2%) | 20 (39.2%) | 23 (45.1%) | 0.69 |
Post opioid n (%) | 49 (48.0%) | 24 (47.1%) | 25 (49.0%) | 0.99 |
Tomita score | 5.6 (2.4) | 5.9 (2.4) | 5.8 (2.6) | 0.94 |
Revised Tokuhashi score | 7.9 (3.1) | 8.0 (3.5) | 8.2 (3.2) | 0.70 |
SINS | 10.5 (3.0) | 10.1 (2.9) | 10.6 (2.5) | 0.51 |
CCS | 6.6 (1.4) | 6.7 (1.0) | 6.4 (1.2) | 0.88 |
Cervical n (%) | 17 (16.7%) | 9 (17.7%) | 8 (15.7%) | 0.99 |
CT/T n (%) | 58 (56.9%) | 30 (58.8%) | 28 (54.9%) | 0.84 |
TL/L/S n (%) | 28 (27.5%) | 13 (25.5%) | 15 (29.4%) | 0.82 |
Emergency n (%) | 26 (25.5%) | 14 (27.5%) | 12 (23.5%) | 0.82 |
Operation time (min) | 202.0 (76.9) | 229.8 (85.4) | 164.6 (72.6) | < 0.0001 |
Blood loss (g) | 347.4 (318.4) | 453.8 (374.0) | 198.3 (211.6) | < 0.0001 |
Complications during surgery n (%) | 3 (2.9%) | 3 (5.9%) | 0 (0%) | 0.24 |
Perioperative Complications n (%) | 14 (13.9%) | 9 (18.0%) | 5 (9.8%) | 0.26 |
Reoperation n (%) | 4 (4.0%) | 2 (3.9%) | 2 (3.9%) | 0.99 |
Death n (%) | 39 (38.2%) | 18 (35.3%) | 21 (41.2%) | 0.68 |
survival days after operation (days) | 291.2 (199.7) | 307.8 (160.3) | 273.5 (186.2) | 0.29 |
